RedCo II Master Fund, L.P. is 10% Owner at ADC Therapeutics SA (ADCT). They have made 3 open-market trades across 2 companies since 2023, most recently 2024-12-04.
CIK 0001921783
2 open-market purchases totalling $4.1M since 2023, against 1 sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.